Transgenic Manufacturing analysis combined with Strategic, Technical and Financial issues constitute a seven-part series based on the research and opinions of a worldwide panel of researchers and other qualified scientists actively engaged in transgenic manufacturing. The participants share their experiences and expectations regarding the market opportunity and key strategies in a new market environment as well as different tools and techniques used in valuation of transgenic manufacturing. These insights can be used to help business intelligence teams, marketing professionals and product developers to better understand the transgenic manufacturing and protein science market from the most important perspective of all - that of their customers.
Content
1.0 Operating tools for transgenic manufacturers
2.0 Therapeutic protein industry - value mapping
3.0 Partnering and business trends in transgenic manufacturing
4.0 Choosing the proper long-term manufacturing strategy - system comparison
5.0 Plant Biotechnology - Evaluating strategic factors
6.0 Revenue Structure and Contract Models for Transgenic Manufacturing and Antibody Licencing
7.0 Financial Modelling and Evaluation of Transgenic Manufacturing